RankingsPricing
  1. US-listed companies
  2. TEVA PHARMACEUTICAL INDUSTRIES LTD
  3. Financials
  4. Operating margin (%)

TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA

Market cap
$27.8B
P/E ratio
SummaryFinancials
Period EndOperating margin (%) YoY (%)
Dec 31, 2024-1.8-167.02%
Dec 31, 20232.7-119.43%
Dec 31, 2022-14.1-230.13%
Dec 31, 202110.8-150.40%
Dec 31, 2020-21.4+717.36%
Dec 31, 2019-2.6-69.79%
Dec 31, 2018-8.7-88.88%
Dec 31, 2017-78.1-894.22%
Dec 31, 20169.8-42.34%
Dec 31, 201517.1-12.48%
Dec 31, 201419.5+140.10%
Dec 31, 20138.1-25.20%
Dec 31, 201210.9-36.08%
Dec 31, 201117-29.29%
Dec 31, 201024

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)